Sangamo BioSciences Inc. | Ownership
Companies that own Sangamo BioSciences Inc.
The Vanguard Group, Inc.
7,957,968
7.83%
1,175,508
0.01%
06/30/2018
BlackRock Fund Advisors
7,335,878
7.22%
1,219,676
0.01%
06/30/2018
SSgA Funds Management, Inc.
6,080,644
5.98%
1,543,693
0.01%
06/30/2018
Wasatch Advisors, Inc.
4,058,167
3.99%
365,186
0.48%
06/30/2018
Fidelity Management & Research Co.
3,319,050
3.26%
-932,409
0.01%
06/30/2018
Adage Capital Management LP
3,250,000
3.2%
950,000
0.13%
06/30/2018
Credit Suisse Securities (USA) LLC (Broker)
1,768,741
1.74%
-165,924
0.04%
06/30/2018
Ecor1 Capital LLC
1,509,671
1.49%
1,509,671
2.86%
06/30/2018
Casdin Capital LLC
1,400,000
1.38%
0
3.54%
06/30/2018
Northern Trust Investments, Inc.
1,292,821
1.27%
228,891
0.01%
06/30/2018
| Address |
Point Richmond Tech Center II
Richmond California 94804
United States
|
|
Employees
|
- |
| Website |
http://www.sangamo.com |
| Updated |
07/08/2019 |
| Sangamo Therapeutics, Inc. researches and develops transcription factors in the regulation of genes. It focuses on the research, development and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation technology platform is enabled by the engineering of a class of transcription factors known as zinc finger DNA-binding proteins. The company was founded by Edward O. |
